0.0664 USD
-0.06 (-46.45%)
0.0356 USD
-0.03 (-46.39%)
We assign a fundamental rating of 1 out of 10 to PTPI. PTPI was compared to 190 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of PTPI have multiple concerns. While showing a medium growth rate, PTPI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- PTPI had negative earnings in the past year.
- PTPI had a negative operating cash flow in the past year.
- PTPI had negative earnings in each of the past 5 years.
- PTPI had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of PTPI (-251.96%) is worse than 92.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -251.96% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-118.22%
ROA(5y)-79.49%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- PTPI has a Gross Margin of 76.28%. This is amongst the best in the industry. PTPI outperforms 84.26% of its industry peers.
- PTPI's Gross Margin has improved in the last couple of years.
- The Profit Margin and Operating Margin are not available for PTPI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 76.28% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.38%
GM growth 5Y7.84%
2. Health
2.1 Basic Checks
- PTPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
- PTPI has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, PTPI has more shares outstanding
- Compared to 1 year ago, PTPI has a worse debt to assets ratio.
2.2 Solvency
- PTPI has an Altman-Z score of -18.76. This is a bad value and indicates that PTPI is not financially healthy and even has some risk of bankruptcy.
- PTPI has a Altman-Z score of -18.76. This is amonst the worse of the industry: PTPI underperforms 80.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -18.76 |
ROIC/WACCN/A
WACC6.75%
2.3 Liquidity
- PTPI has a Current Ratio of 0.40. This is a bad value and indicates that PTPI is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.40, PTPI is not doing good in the industry: 93.91% of the companies in the same industry are doing better.
- A Quick Ratio of 0.33 indicates that PTPI may have some problems paying its short term obligations.
- The Quick ratio of PTPI (0.33) is worse than 93.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.4 | ||
| Quick Ratio | 0.33 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 14.32% over the past year.
- Looking at the last year, PTPI shows a very negative growth in Revenue. The Revenue has decreased by -57.42% in the last year.
- The Revenue for PTPI have been decreasing by -19.98% on average. This is quite bad
EPS 1Y (TTM)14.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320.26%
Revenue 1Y (TTM)-57.42%
Revenue growth 3Y-13.17%
Revenue growth 5Y-19.98%
Sales Q2Q%-87.54%
3.2 Future
- PTPI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.51% yearly.
- PTPI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 43.00% yearly.
EPS Next Y48.83%
EPS Next 2Y21.8%
EPS Next 3Y18.67%
EPS Next 5Y18.51%
Revenue Next Year0.76%
Revenue Next 2Y0.17%
Revenue Next 3Y26.71%
Revenue Next 5Y43%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for PTPI. In the last year negative earnings were reported.
- Also next year PTPI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- PTPI's earnings are expected to grow with 18.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.8%
EPS Next 3Y18.67%
5. Dividend
5.1 Amount
- No dividends for PTPI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PETROS PHARMACEUTICALS INC / PTPI FAQ
What is the fundamental rating for PTPI stock?
ChartMill assigns a fundamental rating of 1 / 10 to PTPI.
Can you provide the valuation status for PETROS PHARMACEUTICALS INC?
ChartMill assigns a valuation rating of 0 / 10 to PETROS PHARMACEUTICALS INC (PTPI). This can be considered as Overvalued.
Can you provide the profitability details for PETROS PHARMACEUTICALS INC?
PETROS PHARMACEUTICALS INC (PTPI) has a profitability rating of 1 / 10.
What is the expected EPS growth for PETROS PHARMACEUTICALS INC (PTPI) stock?
The Earnings per Share (EPS) of PETROS PHARMACEUTICALS INC (PTPI) is expected to grow by 48.83% in the next year.